Need for an addendum on the clinical investigation of medicinal products intended for treatment of glucocorticoid-induced osteoporosis

  • Email
  • Help
Current version

Concept paper

Reference numberCHMP/EWP/15912/10
Published29/01/2010
KeywordsOsteoporosis, glucocorticoids, secondary osteoporosis, postmenopausal osteoporosis, endpoints
DescriptionThis document reflects the need for an addendum on glucocorticoid-induced osteoporosis to the guideline on the clinical investigation of medicinal products used in the treatment of osteoarthritis.

How helpful is this page?

Average rating:

 Based on 0 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
0 ratings
    

Tell us more